Thyrocare Technologies Limited
Morgan Stanley bought 4,56,000 shares of Thyrocare Technologies for ₹28.45 Cr at ₹624.00 apiece in a block deal. On the same day, Thyrocare's promoter, Docon Technologies Private Limited, sold 1,57,69,696 shares, reducing their stake from 60.92% to 51.02% and crossing a disclosure threshold.
A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.